Want to see FR:AELIS full AI Analyst Report?
Aelis Farma SA (AELIS) Ratios
Aelis Farma SA Ratios
FR:AELIS's free cash flow for Q2 2026 was $-2.00M. For the 2026 fiscal year, FR:AELIS's free cash flow was decreased by $-2.00K and operating cash flow was $-2.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.40 | 3.77 | 2.48 | 2.45 | 1.97 |
| Quick Ratio | 4.40 | 3.77 | 2.47 | 2.44 | 1.97 |
| Cash Ratio | 3.51 | 2.92 | 2.02 | 2.18 | 1.74 |
| Solvency Ratio | -0.81 | -0.75 | -0.38 | -0.73 | 0.02 |
| Operating Cash Flow Ratio | -2.30 | -2.40 | -1.25 | -0.83 | 1.33 |
| Short-Term Operating Cash Flow Coverage | -4.28 | -7.83 | -12.84 | -16.17 | 16.71 |
| Net Current Asset Value | $ 2.68M | $ 8.54M | $ 11.79M | $ 19.17M | $ 612.00K |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.55 | 0.32 | 0.15 | 0.10 | 0.23 |
| Debt-to-Equity Ratio | 1.49 | 0.62 | 0.31 | 0.19 | 7.13 |
| Debt-to-Capital Ratio | 0.60 | 0.38 | 0.23 | 0.16 | 0.88 |
| Long-Term Debt-to-Capital Ratio | 0.50 | 0.27 | 0.13 | 0.13 | 0.85 |
| Financial Leverage Ratio | 2.71 | 1.95 | 1.99 | 1.98 | 31.49 |
| Debt Service Coverage Ratio | -4.72 | -4.28 | -5.58 | -17.66 | -0.27 |
| Interest Coverage Ratio | -28.85 | -37.55 | -41.15 | -76.12 | 18.23 |
| Debt to Market Cap | 0.37 | 0.19 | 0.02 | 0.02 | 0.05 |
| Interest Debt Per Share | 0.50 | 0.47 | 0.33 | 0.33 | 0.68 |
| Net Debt to EBITDA | 0.20 | 1.09 | 2.55 | 1.88 | -21.68 |
| Profitability Margins | |||||
| Gross Profit Margin | -13.39% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBIT Margin | -397.36% | -278.12% | -71.96% | -427.86% | 8.91% |
| EBITDA Margin | -383.97% | -268.11% | -70.10% | -426.02% | 9.30% |
| Operating Profit Margin | -397.36% | -288.83% | -71.36% | -223.81% | 28.12% |
| Pretax Profit Margin | -342.61% | -278.12% | -56.05% | -375.09% | 19.38% |
| Net Profit Margin | -308.73% | -278.42% | -56.09% | -375.11% | 6.33% |
| Continuous Operations Profit Margin | -308.73% | -278.42% | -56.09% | -375.11% | 6.33% |
| Net Income Per EBT | 90.11% | 100.11% | 100.06% | 100.01% | 32.63% |
| EBT Per EBIT | 86.22% | 96.29% | 78.55% | 167.59% | 68.93% |
| Return on Assets (ROA) | -53.40% | -37.84% | -19.32% | -36.43% | 2.03% |
| Return on Equity (ROE) | -144.94% | -73.71% | -38.47% | -72.20% | 63.85% |
| Return on Capital Employed (ROCE) | -85.30% | -51.91% | -39.76% | -36.37% | 18.10% |
| Return on Invested Capital (ROIC) | -66.97% | -46.75% | -37.25% | -35.15% | 5.46% |
| Return on Tangible Assets | -54.26% | -38.20% | -19.46% | -36.61% | 2.03% |
| Earnings Yield | -41.54% | -27.20% | -3.02% | -8.91% | 0.47% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.18 | 1.09 | 4.76 | 2.78 | 5.63 |
| Payables Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Fixed Asset Turnover | 1.91 | 2.00 | 7.65 | 21.52 | 46.30 |
| Asset Turnover | 0.17 | 0.14 | 0.34 | 0.10 | 0.32 |
| Working Capital Turnover Ratio | 0.20 | 0.19 | 0.48 | 0.21 | 1.00 |
| Cash Conversion Cycle | 167.79 | 335.56 | 76.72 | 131.19 | 64.80 |
| Days of Sales Outstanding | 167.79 | 335.56 | 76.72 | 131.19 | 64.80 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Days of Payables Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Cycle | 167.79 | 335.56 | 76.72 | 131.19 | 64.80 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.39 | -0.84 | -0.98 | -1.10 | 1.98 |
| Free Cash Flow Per Share | -0.39 | -0.85 | -0.98 | -1.11 | 1.96 |
| Dividend Paid and CapEx Coverage Ratio | -1345.75 | -60.67 | -143.02 | -95.26 | 89.06 |
| Capital Expenditure Coverage Ratio | -1345.75 | -60.67 | -143.02 | -95.26 | 89.06 |
| Operating Cash Flow Coverage Ratio | -0.82 | -1.84 | -3.11 | -3.41 | 2.96 |
| Operating Cash Flow to Sales Ratio | -2.58 | -4.30 | -1.39 | -3.43 | 2.09 |
| Free Cash Flow Yield | -34.78% | -42.75% | -7.53% | -8.23% | 15.52% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -2.40 | -3.68 | -33.15 | -11.22 | 210.57 |
| Price-to-Sales (P/S) Ratio | 7.43 | 10.24 | 18.59 | 42.09 | 13.32 |
| Price-to-Book (P/B) Ratio | 3.49 | 2.71 | 12.75 | 8.10 | 134.45 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -2.88 | -2.34 | -13.28 | -12.16 | 6.44 |
| Price-to-Operating Cash Flow Ratio | -2.88 | -2.38 | -13.37 | -12.28 | 6.37 |
| Price-to-Earnings Growth (PEG) Ratio | 0.19 | -0.10 | 0.49 | 0.01 | -1.66 |
| Enterprise Value Multiple | -1.73 | -2.73 | -23.97 | -8.00 | 121.53 |
| Enterprise Value | 13.88M | 19.61M | 152.14M | 129.74M | 102.57M |
| EV to EBITDA | -1.73 | -2.73 | -23.97 | -8.00 | 121.53 |
| EV to Sales | 6.66 | 7.32 | 16.80 | 34.06 | 11.30 |
| EV to Free Cash Flow | -2.58 | -1.67 | -12.00 | -9.84 | 5.47 |
| EV to Operating Cash Flow | -2.58 | -1.70 | -12.09 | -9.94 | 5.41 |
| Tangible Book Value Per Share | 0.31 | 0.72 | 1.01 | 1.66 | 0.08 |
| Shareholders’ Equity Per Share | 0.32 | 0.74 | 1.02 | 1.67 | 0.09 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.10 | -0.00 | -0.00 | -0.00 | 0.67 |
| Revenue Per Share | 0.15 | 0.20 | 0.70 | 0.32 | 0.95 |
| Net Income Per Share | -0.47 | -0.54 | -0.39 | -1.21 | 0.06 |
| Tax Burden | 0.90 | 1.00 | 1.00 | 1.00 | 0.33 |
| Interest Burden | 0.86 | 1.00 | 0.78 | 0.88 | 2.17 |
| Research & Development to Revenue | 2.77 | 3.71 | 1.79 | 3.62 | 0.76 |
| SG&A to Revenue | 0.59 | 1.25 | 0.12 | 0.44 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.04 | 0.03 | 0.05 |
| Income Quality | 0.84 | 1.55 | 2.48 | 0.91 | 33.05 |
Currency in EUR